In which platelet function disorders would you consider use of Novoseven as opposed to platelet transfusion?
Are there particular clinical scenarios that would affect your decision?
1 Answer
Mednet MemberInvited Expert
Hematology · Mayo Clinic
Answered on
There are now two recombinant activated factor VII (rFVIIa) available in the US. Trade names are NovoSeven RT and SEVENFACT. NovoSeven RT is US FDA approved for use in Glanzmann thrombasthenia. There are case reports of its efficacy in off label use for other inherited platelet function defects. SEV...
Join for free or sign in to see the full answer